Neogen Chemicals opens QIP with ₹2,189.73 floor price per share
- Neogen Chemicals opens QIP with ₹2,189.73 floor price per share
- Preliminary placement document approved on September 10, 2026
- Shareholders approved the issue via special resolution on August 21, 2026
- Company may offer up to 5% discount on the floor price

*this image is generated using AI for illustrative purposes only.
Neogen Chemicals has opened its qualified institutional placement (QIP) with a floor price of ₹2,189.73 per equity share. The Fund-Raising Committee approved the preliminary placement document on September 10, 2026.
The company’s Board of Directors initially approved the issue in its meeting held on July 24, 2026. Shareholders subsequently granted approval through a special resolution passed on August 21, 2026.
Pricing and Regulatory Framework
The floor price was calculated based on the pricing formula prescribed under Regulation 176(1) of the SEBI ICDR Regulations. The relevant date for the QIP is fixed as September 10, 2026.
Under the regulations, the company may offer a discount of up to 5% on the floor price at its discretion. The final issue price will be determined in consultation with the lead managers appointed for the issue.
| Parameter | Detail |
|---|---|
| Floor Price | ₹2,189.73 per share |
| Relevant Date | September 10, 2026 |
| Maximum Discount | 5% on floor price |
Issue Mechanics
The QIP is being conducted in terms of Chapter VI of the SEBI ICDR Regulations and Section 42 of the Companies Act, 2013. Eligible qualified institutional buyers are invited to submit bids via the application form.
The preliminary placement document dated September 10, 2026, has been filed with both the BSE Limited and the National Stock Exchange of India Limited. The document is also available on the company’s website under the Issue of Securities tab.
Historical Stock Returns for Neogen Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +5.93% | +11.82% | +17.57% | +70.64% | +53.17% | +106.33% |
How will the final issue price, potentially discounted by up to 5%, impact Neogen Chemicals' post-issue valuation and market capitalization?
What specific strategic initiatives or debt reduction plans is Neogen Chemicals targeting with the proceeds from this QIP?
Which qualified institutional buyers are likely to participate, and how might their involvement signal confidence in the company's long-term growth trajectory?


































